BKE vs TSLA

BKE's Piotroski F-Score of 4/9 indicates weak financial health, signaling potential distress in operational efficiency and capital structure. The absence of an Altman Z-Score raises concern about bankruptcy risk, though the company maintains strong profitability metrics including a 41.26% ROE and 16.13% profit margin. Trading at $50.28, the stock is below its intrinsic value of $84.46 and Graham Number of $30.6, suggesting undervaluation on a defensive basis, but the lack of analyst coverage and neutral insider activity limit conviction. The 52-week range ($33.12–$61.69) and recent 6-month decline highlight volatility, while earnings growth remains solid but inconsistent.

Tesla's deterministic health is stable with a Piotroski F-Score of 4/9, but its valuation is fundamentally disconnected from current performance. The Graham Number ($22.85) and Intrinsic Value ($7.42) indicate extreme overvaluation relative to the current price of $343.25. With negative YoY revenue growth (-3.10%) and a collapse in earnings growth (-60.60%), the P/E ratio of 323.82 is unsustainable. Technical trends and insider activity are both strongly bearish, suggesting a significant correction is likely.